Advertisement

Picture EBD Group Bio-Europe Spring 2023 Basel 560x80px

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2669 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
DeuterOncology N.V.. (1/19/23). "Press Release: DeuterOncology closes €5.65M Series A financing round". Liège. 2023-01-19
Bayer AG. (1/18/23). "Press Release: Bayer Acquires Blackford Analysis Ltd. Bolstering the company’s Position in Digital Medical Imaging [ Not intended for U.S. and UK Media ]". Berlin. 2023-01-18
Green Bioactives Ltd.. (1/17/23). "Press Release: Green Bioactives Appoints Experienced Biotech Leaders Chris Meaney and Andy Hall-Ponselé to Expand Senior Management Team". Edinburgh. 2023-01-17
BioGeneration Ventures B.V.. (1/17/23). "Press Release: BGV Appoints Jaap de Bruin as FIRST Fund Investment Manager and Promotes Rianne Ellenbroek to Principal". Amsterdam. 2023-01-17
Optibrium Ltd.. (1/17/23). "Press Release: Optibrium Appoints Steve Yemm as Chief Commercial Officer". Cambridge. 2023-01-17
AstraZeneca plc. (1/16/23). "Press Release: Acquisition of Neogene Therapeutics Completed". 2023-01-16
BioNTech SE. (1/10/23). "Press Release: BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development". Mainz & London. 2023-01-10
Astrea Bioseparations. (1/9/23). "Press Release: Astrea Bioseparations Acquires Delta Precision Ltd, a Leading Manufacturer of Chromatography Columns for Biomanufacturing". 2023-01-09
Proteros Biostructures GmbH. (1/9/23). "Press Release: Proteros Receives Minority Investment from Private Equity Firm Inflexion". Martinsried. 2023-01-09
AstraZeneca plc. (1/9/23). "Press Release: AstraZeneca to Acquire CinCor Pharma to Strengthen Cardiorenal Pipeline". 2023-01-09
Chiesi Farmaceutici S.p.A.. (1/8/23). "Press Release: Chiesi Farmaceutici S.p.A. to Acquire Amryt Pharma Plc". Parma, Boston, MA & Dublin. 2023-01-08
CureVac N.V.. (1/6/23). "Press Release: CureVac Announces Positive Data on Joint COVID-19 and Flu mRNA Vaccine Development Programs". Tübingen & Boston, MA. 2023-01-06
BioNTech SE. (1/6/23). "Press Release: BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030". Mainz. 2023-01-06
Akamis Bio Ltd.. (1/5/23). "Press Release: Akamis Bio Announces $30 Million Financing, Provides Clinical Program Update and Relaunches with Name Change from PsiOxus Therapeutics". Cambridge, MA & Oxford. 2023-01-05
Actimed Therapeutics Ltd.. (1/4/23). "Press Release: Actimed Therapeutics Successfully Closes Second Tranche of £10m Seed Financing". London. 2023-01-04
Oxford Biomedica plc. (12/22/22). "Press Release: Oxford Biomedica to Present at 41st Annual J.P. Morgan Healthcare Conference". Seattle, WA. 2022-12-22
Stifel Financial Corporation. (12/22/22). "Press Release: Stifel to Acquire Torreya Partners". St. Louis, MO. 2022-12-22
Merck & Co., Inc.. (12/21/22). "Press Release: Lynparza (olaparib) in Combination With Abiraterone and Prednisone or Prednisolone Approved in the EU as Treatment for Certain Patients With Metastatic Castration-Resistant Prostate Cancer". Rahway, NJ. 2022-12-21
Ethris GmbH. (12/21/22). "Press Release: Ethris Announces Collaboration with DIOSynVax and CEPI to Develop a Broadly Protective mRNA Vaccine Against Betacoronaviruses". Munich. 2022-12-21
CN Bio Innovations Ltd.. (12/19/22). "Press Release: CN Bio Appoints Dr Paul Brooks as Chief Executive Officer". Cambridge. 2022-12-19
Lift BioSciences Ltd.. (12/19/22). "Press Release: Lift BioSciences Investors Increase Investment in Lift and Johnson and Johnson Welcomes Lift into JLABS". London. 2022-12-19
Minervax ApS. (12/15/22). "Press Release: Minervax Announces 72M EUR Financing to Advance Development of Novel Vaccine against Group B Streptococcus". Copenhagen. 2022-12-15
PhoreMost Ltd.. (12/14/22). "Press Release: PhoreMost and ThinkCyte Collaborate to Advance AI Based Drug Discovery". Cambridge. 2022-12-14
PrecisionLife Ltd.. (12/14/22). "Press Release: PrecisionLife Enters into a Multi Target R&D Collaboration Agreement with Ono Pharmaceutical". Oxford. 2022-12-14
Storm Therapeutics Ltd.. (12/14/22). "Press Release: Storm Therapeutics Announces Closing of USD $30M Series B Financing". Cambridge. 2022-12-14
Oxford Biomedica plc. (12/14/22). "Press Release: Oxford Biomedica Solutions Forms New Partnerships with Three Biotechnology Companies". Oxford. 2022-12-14
BehaVR, Inc.. (12/13/22). "Press Release: BehaVR and OxfordVR Combine and Raise Series B to Create Largest VR Delivery Platform for Evidence-Based Digital Therapeutics". Nashville, TN & Oxford. 2022-12-13
Green Bioactives Ltd.. (12/13/22). "Press Release: Green Bioactives Completes £2.6m Seed Financing to Advance Its Sustainable Plant Products Biomanufacturing Platform". Edinburgh. 2022-12-13
Amgen Inc.. (12/12/22). "Press Release: Rule 2.7 Announcement. Amgen Inc to Acquire Horizon Therapeutics plc". Thousand Oaks, CA. 2022-12-12
Molecular Devices, LLC. (12/6/22). "Press Release: Molecular Devices Adds Proprietary Patient-derived Organoid Technology with Acquisition of Cellesce". San José, CA & Cardiff. 2022-12-06
Entact Bio. (12/6/22). "Press Release: Entact Bio Launches with $81 Million Series A to Develop Precision Medicines for Targeted Protein Enhancement". Watertown, MA. 2022-12-06
Coulter Partners. (12/6/22). "Press Release: Coulter Partners Appoints Dr. Hannah Musisi as Executive Director". 2022-12-06
Genezen, Inc.. (11/29/22). "Press Release: Genezen Appoints Chief Commercial Officer to Executive Leadership Team". 2022-11-29
AstraZeneca plc. (11/29/22). "Press Release: AstraZeneca to Acquire Neogene Therapeutics, Accelerating Ambition in Oncology Cell Therapy". 2022-11-29
Touchlight Genetics Ltd.. (11/29/22). "Press Release: Touchlight Receives Grant to Advance Rapid, Scalable and Thermostable doggybone DNA Vaccine Platform". Hampton. 2022-11-29
Rgenta Therapeutics, Inc.. (11/29/22). "Press Release: Rgenta Therapeutics Raises $52M in Series A Financing". Cambridge, MA. 2022-11-29
V7 Ltd.. (11/28/22). "Press Release: V7 Raises a $33m Series A to Help Teams Build Robust AI, Faster". London. 2022-11-28
Turbine Simulated Cell Technologies Ltd.. (11/22/22). "Press Release: Turbine Raises €20 Million in Series A Financing to Advance Programs & Partnerships Towards the Clinic with World’s First Cancer Cell Simulation Platform". London & Budapest. 2022-11-22
Oxford Biomedica plc. (11/22/22). "Press Release: Oxford Biomedica Appoints Dr Frank Mathias as Chief Executive Officer". Oxford. 2022-11-22
Accession Therapeutics. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. 2022-11-21
European Invesmtent Bank (EIB). (11/18/22). "Press Release: Marjut Falkstedt Appointed as Chief Executive of the European Investment Fund". 2022-11-18
Cradle Bio B.V.. (11/17/22). "Press Release: Biotech Startup Cradle Exits Stealth, Raises $5.5M to Design Protein-machines and Cell-factories with AI". 2022-11-17
Valneva S.E.. (11/17/22). "Press Release: Valneva Appoints Dipal Patel as Chief Commercial Officer". Saint-Herblain. 2022-11-17
Kriya Therapeutics, Inc.. (11/16/22). "Press Release: Kriya Acquires Redpin Therapeutics, Adding Neurology Pipeline to Gene Therapy Portfolio". Redwood City, CA & Research Triangle Park, NC. 2022-11-16
Rentschler Biopharma SE. (11/16/22). "Press Release: Rentschler Biopharma Appoints Christiane Bardroff as Chief Operating Officer and Member of the Executive Board". Laupheim. 2022-11-16
Touchlight Genetics Ltd.. (11/15/22). "Press Release: Touchlight Signs License Agreement with Voyager for Use of Touchlight’s DNA Technology in Voyager’s Capsid Discovery Platform". Hampton. 2022-11-15
Sartorius AG. (11/11/22). "Press Release: Sartorius Successfully Places Schuldschein Loans with a Volume of 650 Million Euros". Göttingen. 2022-11-11
NRG Therapeutics Ltd.. (11/9/22). "Press Release: NRG Therapeutics Announces £16 Million Series A to Advance Mitochondrial Therapeutics for Parkinson’s and ALS". Stevenage. 2022-11-09
Atriva Therapeutics GmbH. (11/9/22). "Press Release: Atriva Therapeutics Appoints Christian Pangratz as Chief Executive Officer, Implementing Planned Management Change". Tübingen, Frankfurt a.M. & Martinsried. 2022-11-09
PrecisionLife Ltd.. (11/8/22). "Press Release: PrecisionLife to Evaluate Precision Medicine Potential of Sosei Heptares Neuroscience GPCR Target". 2022-11-08
BC Platforms AG. (11/8/22). "Press Release: BC Platforms Announces USD 20 Million Growth Financing Led by Jolt Capital". 2022-11-08
VectorY B.V.. (11/8/22). "Press Release: VectorY Appoints Sander van Deventer as CEO and Makes Key Appointments to Its Leadership Team". Amsterdam. 2022-11-08
Adaptimmune Therapeutics plc. (11/8/22). "Press Release: Adaptimmune Reports Third-Quarter Financial Results and Business Update". Philadelphia, PA & Oxford. 2022-11-08
BioGeneration Ventures B.V.. (11/8/22). "Press Release: BGV Appoints Elena Ritsou as Venture Partner and Andree Blaukat as Senior Advisor". Amsterdam. 2022-11-08
Ubiquigent Ltd.. (11/7/22). "Press Release: Ubiquigent Appoints Dr Hozefa Amijee as Head of Business Development". Dundee. 2022-11-07
OxSonics Therapeutics Ltd.. (11/7/22). "Press Release: Jérôme Marzinski Appointed as Chief Executive Officer". Oxford. 2022-11-07
Bruker Corporation. (11/7/22). "Press Release: Bruker Corporation to Participate in the 2022 Jefferies London Healthcare Conference". Billerica, MA. 2022-11-07
Exscientia plc. (11/3/22). "Press Release: Exscientia Expands Biologics Design Capability with Automated Laboratory". Oxford. 2022-11-03
Affimed N.V.. (11/1/22). "Press Release: Affimed to Present at the 2022 Jefferies London Healthcare Conference". Heidelberg. 2022-11-01
Exscientia plc. (11/1/22). "Press Release: Exscientia to Present at Upcoming Investor Conferences in November". Oxford. 2022-11-01
Eagle Genomics Ltd.. (10/31/22). "Press Release: Eagle Genomics Announces USD 20M First Close, Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation". Cambridge. 2022-10-31
Thermo Fisher Scientific Inc.. (10/31/22). "Press Release: Thermo Fisher Scientific to Acquire The Binding Site Group". Waltham, MA. 2022-10-31
PhoreMost Ltd.. (10/28/22). "Press Release: PhoreMost Enters Multi-target Collaboration with Targeted Protein Degradation Leader Arvinas". Cambridge. 2022-10-28
MorphoSys AG. (10/27/22). "Press Release: GSK, MorphoSys’ Licensing Partner, Provides Update on ContRAst Phase III Program for Otilimab in Moderate to Severe Rheumatoid Arthritis". Planegg. 2022-10-27
Medicines Discovery Catapult (MDC). (10/26/22). "Press Release: Medicines Discovery Catapult Appoints International Entrepreneur Volker Hirsch to Bolster Commercial Expertise". 2022-10-26
Proteros Biostructures GmbH. (10/25/22). "Press Release: Proteros and Adrestia Initiate Multi-target Partnership to Discover First-in-class Drugs for Intractable Genetic Diseases". Martinsried. 2022-10-25
Adaptimmune Therapeutics plc. (10/25/22). "Press Release: Adaptimmune Enhances Its Pipeline of Wholly Owned Cell Therapies for Cancer with Transfer of PRAME and NY-ESO Target Programs from GSK". Philadelphia, PA & Oxford. 2022-10-25
Green Bioactives Ltd.. (10/24/22). "Press Release: Green Bioactives Appoints David McElroy as CEO ". Edinburgh. 2022-10-24
AbbVie Inc.. (10/20/22). "Press Release: AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline". North Chicago, IL. 2022-10-20
Enhanc3D Genomics Ltd.. (10/20/22). "Press Release: Enhanc3D Genomics Raises £10 Million in Series A Financing to Advance GenLink3D Proprietary Technology Platform". Cambridge. 2022-10-20
Nucleome Therapeutics Ltd.. (10/19/22). "Press Release: Nucleome Therapeutics Raises oversubscribed £37.5 Million Series A Financing to Decode the Dark Matter of the Human Genome and Deliver First-in-Class Precision Medicines". Oxford. 2022-10-19
Empyrean Neuroscience, Inc.. (10/18/22). "Press Release: Empyrean Neuroscience Launches with $22M Series A and Genetic Engineering Platform to Advance Pipeline of Neuroactive Compounds Targeting CNS Disorders". New York, NY & Cambridge. 2022-10-18
GSK plc. (10/18/22). "Press Release: GSK Announces Expanded Collaboration with Tempus in Precision Medicine to Accelerate R&D". London. 2022-10-18
Innovation Zero. (10/17/22). "Press Release: Major Climate and Cleantech Congress Announces First International Trade and Innovation Keynote Speakers". London. 2022-10-17
Co.don AG. (10/17/22). "Pressemitteilung: Vereinbarung über die Veräußerung des Geschäftsbetriebs". Teltow & Leipzig. 2022-10-17
PBD Biotech Ltd.. (10/17/22). "Press Release: PBD Biotech Raises further £2.4m for Its Breakthrough Tuberculosis Blood Test". 2022-10-17
Illumina, Inc.. (10/11/22). "Press Release: Illumina Launches Strategic Research Collaboration with AstraZeneca to Accelerate Drug Target Discovery". San Diego, CA. 2022-10-11
Andera Partners. (10/10/22). "Press Release: Andera Partners Raises Its Largest Life Sciences Fund at €456M, Demonstrating the Attractiveness of Its Activity and of the Sector". Paris. 2022-10-10
Immunic, Inc.. (10/10/22). "Press Release: Immunic, Inc. Announces $60.0 Million Oversubscribed Private Placement Equity Financing". New York, NY. 2022-10-10
OSE Immunotherapeutics S.A.. (10/7/22). "Press Release: OSE Immunotherapeutics Appoints Nicolas Poirier as Chief Executive Officer". Nantes. 2022-10-07
Cytiva. (10/6/22). "Press Release: Cytiva Strengthens Cell Line Development with Cevec Acquisition". 2022-10-06
Coulter Partners. (10/6/22). "Press Release: Coulter Partners and Differing Minds Announce Partnership Agreement". 2022-10-06
NLC Ventures Netherlands B.V.. (10/5/22). "Press Release: Crainio, an NLC Venture, Sets Out to Revolutionise the Measurement of Intracranial Pressure (ICP) by Developing a Non-invasive Measuring Device". 2022-10-05
Araris Biotech AG. (10/4/22). "Press Release: Araris Biotech Closes $24 Million Financing Round". Zurich. 2022-10-04
Sibylla Biotech S.p.A.. (10/4/22). "Press Release: Sibylla Biotech Raises €23 Million Series A to Advance Protein Degradation by Folding Interference Pipeline and Expand Technology Platform". Verona. 2022-10-04
LogicBio Therapeutics, Inc.. (10/3/22). "Press Release: Alexion, AstraZeneca Rare Disease to Acquire LogicBio Therapeutics to Accelerate Growth in Genomic Medicine". Lexington, MA. 2022-10-03
Sartorius AG. (9/30/22). "Press Release: Sartorius Completes Acquisition of Albumedix". Göttingen. 2022-09-30
Xund Solutions GmbH. (9/29/22). "Press Release: Healthtech Start-up Xund Raises €6m – One of the Largest Seed Rounds to Date in Austria". 2022-09-29
Pheon Therapeutics Ltd.. (9/28/22). "Press Release: Pheon Therapeutics Launches with $68 Million in Financing to Advance Novel Antibody-Drug Conjugates for Treatment of Solid Tumors". London. 2022-09-28
GSK plc. (9/22/22). "Press Release: GSK and Spero Therapeutics Announce Exclusive Licence Agreement for tebipenem HBr, a Late-stage Antibiotic that May Treat Complicated Urinary Tract Infections". London. 2022-09-22
Merck KGaA. (9/21/22). "Press Release: Merck Opens New € 29 Million Biologics Testing Center in Shanghai". Shanghai. 2022-09-21
Gilead Sciences, Inc.. (9/20/22). "Press Release: Gilead Sciences Completes Acquisition of MiroBio". Foster City, CA. 2022-09-20
Forever Healthy Foundation gGmbH. (9/15/22). "Press Release: Rejuvenation Startup Summit 2022 Announces Program and Speakers". 2022-09-15
Tridek-One S.A.S.. (9/15/22). "Press Release: Tridek-One Closes a €16 Million Financing Round to Develop First-in-Class Immune Checkpoint Agonists". Paris. 2022-09-15
SparingVision S.A.S.. (9/14/22). "Press Release: SparingVision Raises €75 Million Series B to Continue Building World-Leading Portfolio of Genomic Medicines for Ocular Diseases". 2022-09-14
Beckman Coulter Life Sciences. (9/13/22). "Press Release: ValitaCell Joins Beckman Coulter Life Sciences". Indianapolis, IN & Dublin. 2022-09-13
Ori Biotech Ltd.. (9/13/22). "Press Release: Ori Biotech and CTMC Partner to Accelerate Novel Cell Therapy Delivery". London & Houston, TX. 2022-09-13
Pretzel Therapeutics. (9/12/22). "Press Release: Pretzel Therapeutics Launches with $72.5 Million Series A Financing to Pioneer Mitochondrial Therapies". Waltham, MA. 2022-09-12
AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. 2022-09-08
MeiraGTx Holdings plc. (9/8/22). "Press Release: MeiraGTx to Participate in Upcoming Investor Conferences". London & New York, NY. 2022-09-08
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  next pagenext page



Advertisement

Picture EBD Group Bio-Europe Spring 2023 Basel 560x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture EBD Group Whitepaper State of Innovation in Europe 650x300px

» top